A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

NCT03525613 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

637

Enrollment

INDUSTRY

Sponsor class

Conditions

Geographic Atrophy

Interventions

DRUG: APL-2
DRUG: APL-2
OTHER: Sham Procedure
OTHER: Sham Procedure

Sponsor

Apellis Pharmaceuticals, Inc.